A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 2, 2012, Pages 653-660

  Lips, Irene M ^a   Van Gils, Carla H ^a   Kotte, Alexis N T J ^a   Van Leerdam, Monique E ^b   Franken, Stefan P G ^a   Van Der Heide, Uulke A ^a   Van Vulpen, Marco ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Intensity modulated radiation therapy; Intrafraction motion; Magnesium oxide; Prostate cancer; Randomized trial

Indexed keywords

ACUTE TOXICITY; CLINICAL PRACTICES; EXPLORATORY ANALYSIS; INTENSITY MODULATED RADIATION THERAPY; INTENSITY-MODULATED RADIOTHERAPY; INTRAFRACTION MOTION; PROSTATE CANCERS; QUALITY OF LIFE; RANDOMIZED CLINICAL TRIALS; RANDOMIZED TRIAL; STATISTICALLY SIGNIFICANT DIFFERENCE;

DISEASES; MAGNESIA; RADIOTHERAPY; TOXICITY; UROLOGY;

MAGNESIUM;

MAGNESIUM OXIDE; PLACEBO;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

AGED; CATHARTICS; DOUBLE-BLIND METHOD; FIDUCIAL MARKERS; HUMANS; MAGNESIUM OXIDE; MALE; MOVEMENT; PROSTATE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84861100918     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.07.030     Document Type: Article

References (30)

1. M.H. Smitsmans, J.W. Wolthaus, and X. Artignan Automatic localization of the prostate for on-line or off-line image-guided radiotherapy Int J Radiat Oncol Biol Phys 60 2004 623 635 (Pubitemid 39233485)
2. A.J. Nederveen, H. Dehnad, and U.A. van der Heide Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials Radiother Oncol 68 2003 81 88 (Pubitemid 37289340)
3. I.M. Lips, H. Dehnad, and C.H. van Gils High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: Acute and late toxicity in 331 patients Radiat Oncol 3 2008 15
4. A.J. Nederveen, U.A. van der Heide, and H. Dehnad Measurements and clinical consequences of prostate motion during a radiotherapy fraction Int J Radiat Oncol Biol Phys 53 2002 206 214 (Pubitemid 34465826)
5. A.M. Nichol, P.R. Warde, and G.A. Lockwood A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion Int J Radiat Oncol Biol Phys 77 2010 1072 1078
6. J. Wu, T. Haycocks, and H. Alasti Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers Radiother Oncol 61 2001 127 133 (Pubitemid 33016571)
7. M.H. Smitsmans, F.J. Pos, and J. de Bois The influence of a dietary protocol on cone beam CT-guided radiotherapy for prostate cancer patients Int J Radiat Oncol Biol Phys 71 2008 1279 1286 (Pubitemid 351842600)
8. P. Chan, R. Dinniwell, and M.A. Haider Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: A cinematic-MRI point-of-interest study Int J Radiat Oncol Biol Phys 70 2008 1507 1515
9. J.H. Xing, and E.E. Soffer Adverse effects of laxatives Dis Colon Rectum 44 2001 1201 1209 (Pubitemid 32758279)
10. A.J. Nederveen, U.A. van der Heide, and P. Hofman Partial boosting of prostate tumours Radiother Oncol 61 2001 117 126 (Pubitemid 33016570)
11. M.R. Moman, U.A. van der Heide, and A.N. Kotte Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life Radiother Oncol 96 2010 38 42
12. I.M. Lips, C.H. van Gils, and U.A. van der Heide Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification BJU Int 103 2009 762 767
13. U.A. van der Heide, A.N. Kotte, and H. Dehnad Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer Radiother Oncol 82 2007 38 45 (Pubitemid 46097130)
14. Dallal GE. DESIGN: A supplementary module for SYSTAT and SYGRAPH. 1988.
15. I.M. Lips, U.A. van der Heide, and A.N. Kotte Effect of translational and rotational errors on complex dose distributions with off-line and on-line position verification Int J Radiat Oncol Biol Phys 74 2009 1600 1608
16. A. Nederveen, J. Lagendijk, and P. Hofman Detection of fiducial gold markers for automatic on-line megavoltage position verification using a marker extraction kernel (MEK) Int J Radiat Oncol Biol Phys 47 2000 1435 1442 (Pubitemid 30421198)
17. A.N. Kotte, P. Hofman, and J.J. Lagendijk Intrafraction motion of the prostate during external-beam radiation therapy: Analysis of 427 patients with implanted fiducial markers Int J Radiat Oncol Biol Phys 69 2007 419 425 (Pubitemid 47380089)
18. J. Adamson, and Q. Wu Optimizing monoscopic kV fluoro acquisition for prostate intrafraction motion evaluation Phys Med Biol 54 2009 117 133
19. Su Z, Zhang L, Murphy M, Williamson J. Analysis of prostate patient setup and tracking data: Potential intervention strategies. Int J Radiat Oncol Biol Phys. In press.
20. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181 (Pubitemid 36962641)
21. M.C. Hornbrook, and M.J. Goodman Assessing relative health plan risk with the RAND-36 health survey Inquiry 32 1995 56 74
22. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376 (Pubitemid 23073154)
23. G. Borghede, and M. Sullivan Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy: Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30 Qual Life Res 5 1996 212 222 (Pubitemid 26180669)
24. D. Osoba, A. Bezjak, and M. Brundage Analysis and interpretation of health-related quality-of-life data from clinical trials: Basic approach of the national cancer institute of canada clinical trials group Eur J Cancer 41 2005 280 287 (Pubitemid 40126961)
25. B. Movsas, J. Moughan, and L. Sarna Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: An analysis of RTOG 9801 J Clin Oncol 27 2009 5816 5822
26. B.L. Madsen, R.A. Hsi, and H.T. Pham Intrafractional stability of the prostate using a stereotactic radiotherapy technique Int J Radiat Oncol Biol Phys 57 2003 1285 1291 (Pubitemid 37443966)
27. I. Ogino, H. Uemura, and T. Inoue Reduction of prostate motion by removal of gas in rectum during radiotherapy Int J Radiat Oncol Biol Phys 72 2008 456 466
28. A.R. Padhani, V.S. Khoo, and J. Suckling Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI Int J Radiat Oncol Biol Phys 44 1999 525 533 (Pubitemid 29258426)
29. E.N. van Lin, L.P. van der Vight, and J.A. Witjes The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: A comparative study Int J Radiat Oncol Biol Phys 61 2005 278 288 (Pubitemid 40039132)
30. S.T. Peeters, M.S. Hoogeman, and W.D. Heemsbergen Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 63 2005 1142 1152 (Pubitemid 41505294)